Nucleome Therapeutics (private company)
See something wrong or missing? Let us know
Offices:London
Business model:B2B
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 43.51M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Nucleome Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Beckley Psytech
63%
|
|
![]() |
CatalYm
63%
|
|
![]() |
Cinclus Pharma
63%
|
|
![]() |
InnovaFeed SAS
63%
|
|
![]() |
Memo Therapeutics
63%
|
|
![]() |
NMD Pharma
63%
|
|
![]() |
Peptomyc
63%
|
|
![]() |
Peptone
63%
|
|
![]() |
ReViral
63%
|
|
![]() |
Salvia BioElectronics
63%
|
|